115 related articles for article (PubMed ID: 27600052)
1. Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014.
Mataseje LF; Abdesselam K; Vachon J; Mitchel R; Bryce E; Roscoe D; Boyd DA; Embree J; Katz K; Kibsey P; Simor AE; Taylor G; Turgeon N; Langley J; Gravel D; Amaratunga K; Mulvey MR
Antimicrob Agents Chemother; 2016 Nov; 60(11):6787-6794. PubMed ID: 27600052
[TBL] [Abstract][Full Text] [Related]
2. Carbapenem-producing
Dos Santos S; Moussounda M; Togola M; Avoune Nguema E; Matteya C; Bignoumba M; Onanga R; Lekana-Douki JB; François P; van der Mee-Marquet N
Front Cell Infect Microbiol; 2024; 14():1341161. PubMed ID: 38390622
[TBL] [Abstract][Full Text] [Related]
3. Pervasive transmission of a carbapenem resistance plasmid in the gut microbiota of hospitalized patients.
León-Sampedro R; DelaFuente J; Díaz-Agero C; Crellen T; Musicha P; Rodríguez-Beltrán J; de la Vega C; Hernández-García M; ; López-Fresneña N; Ruiz-Garbajosa P; Cantón R; Cooper BS; San Millán Á
Nat Microbiol; 2021 May; 6(5):606-616. PubMed ID: 33782584
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome.
de Maio Carrilho CM; de Oliveira LM; Gaudereto J; Perozin JS; Urbano MR; Camargo CH; Grion CM; Levin AS; Costa SF
BMC Infect Dis; 2016 Nov; 16(1):629. PubMed ID: 27809803
[TBL] [Abstract][Full Text] [Related]
5. Contamination of hospital drains and toilets by carbapenemase-producing Enterobacterales: a prevalence study apart from any outbreak context.
Durand C; Jolivet S; Le Neindre K; Couturier J; Lazare C; Montagne T; Nou G; Leplay C; Barbut F
J Hosp Infect; 2024 May; 147():221-223. PubMed ID: 38316258
[No Abstract] [Full Text] [Related]
6. A practical approach to screening for carbapenemase-producing Enterobacterales- views of a group of multidisciplinary experts from English hospitals.
Jenkins DR; Auckland C; Chadwick C; Dodgson AR; Enoch DA; Goldenberg SD; Hussain A; Martin J; Spooner E; Whalley T
BMC Infect Dis; 2024 Apr; 24(1):444. PubMed ID: 38671365
[TBL] [Abstract][Full Text] [Related]
7. Dissemination of carbapenemase-producing Enterobacteriaceae and associated resistance determinants through global food systems.
Harding-Crooks R; Smith D; Fanning S; Fox EM
Compr Rev Food Sci Food Saf; 2023 Jul; 22(4):2706-2727. PubMed ID: 37083194
[TBL] [Abstract][Full Text] [Related]
8. Search and Contain: Impact of an Integrated Genomic and Epidemiological Surveillance and Response Program for Control of Carbapenemase-producing Enterobacterales.
Lane CR; Brett J; Schultz M; Gorrie CL; Stevens K; Cameron DRM; St George S; van Diemen A; Easton M; Stuart RL; Sait M; Peleg AY; Stewardson AJ; Cheng AC; Spelman DW; Waters MJ; Ballard SA; Sherry NL; Williamson DA; Romanes F; Sutton B; Kwong JC; Seemann T; Goncalves da Silva A; Stephens N; Howden BP
Clin Infect Dis; 2021 Dec; 73(11):e3912-e3920. PubMed ID: 32663248
[TBL] [Abstract][Full Text] [Related]
9. [Multi-resistant Enterobacterales and travel].
Massiha K; Eperon G; Andrey D
Rev Med Suisse; 2024 May; 20(872):866-871. PubMed ID: 38693798
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of antimicrobial use in a network of Canadian hospitals in 2002 and 2009.
Taylor G; Gravel D; Saxinger L; Bush K; Simmonds K; Matlow A; Embree J; Le Saux N; Johnston L; Suh KN; Embil J; Henderson E; John M; Roth V; Wong A;
Can J Infect Dis Med Microbiol; 2015; 26(2):85-9. PubMed ID: 26015790
[TBL] [Abstract][Full Text] [Related]
11. Carbapenemase-producing Enterobacteriaceae in the UK: a national study (EuSCAPE-UK) on prevalence, incidence, laboratory detection methods and infection control measures.
Trepanier P; Mallard K; Meunier D; Pike R; Brown D; Ashby JP; Donaldson H; Awad-El-Kariem FM; Balakrishnan I; Cubbon M; Chadwick PR; Doughton M; Doughton R; Hardiman F; Harvey G; Horner C; Lee J; Lewis J; Loughrey A; Manuel R; Parsons H; Perry JD; Vanstone G; White G; Shetty N; Coia J; Wiuff C; Hopkins KL; Woodford N
J Antimicrob Chemother; 2017 Feb; 72(2):596-603. PubMed ID: 27687074
[TBL] [Abstract][Full Text] [Related]
12. A Pilot Study on Carbapenemase Detection: Do We See the Same Level of Agreement as with the CLSI Observations.
Pragasam AK; Sahni RD; Anandan S; Sharma A; Gopi R; Hadibasha N; Gunasekaran P; Veeraraghavan B
J Clin Diagn Res; 2016 Jul; 10(7):DC09-13. PubMed ID: 27630840
[TBL] [Abstract][Full Text] [Related]
13. Outbreaks of colistin-resistant and colistin-susceptible KPC-producing Klebsiella pneumoniae in a Brazilian intensive care unit.
Rossi Gonçalves I; Ferreira ML; Araujo BF; Campos PA; Royer S; Batistão DW; Souza LP; Brito CS; Urzedo JE; Gontijo-Filho PP; Ribas RM
J Hosp Infect; 2016 Dec; 94(4):322-329. PubMed ID: 27654515
[TBL] [Abstract][Full Text] [Related]
14. Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States.
Bartsch SM; McKinnell JA; Mueller LE; Miller LG; Gohil SK; Huang SS; Lee BY
Clin Microbiol Infect; 2017 Jan; 23(1):48.e9-48.e16. PubMed ID: 27642178
[TBL] [Abstract][Full Text] [Related]
15. Increasing incidence of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Belgian hospitals.
De Laveleye M; Huang TD; Bogaerts P; Berhin C; Bauraing C; Sacré P; Noel A; Glupczynski Y;
Eur J Clin Microbiol Infect Dis; 2017 Jan; 36(1):139-146. PubMed ID: 27639859
[TBL] [Abstract][Full Text] [Related]
16. Carbapenem-resistant Enterobacteriaceae: Prevalence and Risk Factors in a Single Community-Based Hospital in Korea.
Lee HJ; Choi JK; Cho SY; Kim SH; Park SH; Choi SM; Lee DG; Choi JH; Yoo JH
Infect Chemother; 2016 Sep; 48(3):166-173. PubMed ID: 27659436
[TBL] [Abstract][Full Text] [Related]
17. Carbapenem Resistance in Clonally Distinct Clinical Strains of Vibrio fluvialis Isolated from Diarrheal Samples.
Chowdhury G; Pazhani GP; Sarkar A; Rajendran K; Mukhopadhyay AK; Bhattacharya MK; Ghosh A; Ramamurthy T
Emerg Infect Dis; 2016 Oct; 22(10):1754-61. PubMed ID: 27649032
[TBL] [Abstract][Full Text] [Related]
18. A Novel Risk Factor Associated With Colonization by Carbapenemase-Producing Enterobacteriaceae: Use of Proton Pump Inhibitors in Addition to Antimicrobial Treatment.
Cheng VC; Chen JH; So SY; Wong SC; Chau PH; Wong LM; Ching RH; Ng MM; Lee WM; Hung IF; Ho PL; Yuen KY
Infect Control Hosp Epidemiol; 2016 Dec; 37(12):1418-1425. PubMed ID: 27619653
[TBL] [Abstract][Full Text] [Related]
19. Incidence of ESBLs and carbapenemases among Enterobacterales and carbapenemases in Pseudomonas aeruginosa isolates collected globally: results from ATLAS 2017-2019.
Gales AC; Stone G; Sahm DF; Wise MG; Utt E
J Antimicrob Chemother; 2023 Jul; 78(7):1606-1615. PubMed ID: 37161662
[TBL] [Abstract][Full Text] [Related]
20. The rapid spread of carbapenem-resistant Enterobacteriaceae.
Potter RF; D'Souza AW; Dantas G
Drug Resist Updat; 2016 Nov; 29():30-46. PubMed ID: 27912842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
